Introduction
The subject of this article is the use of large-tip ablation catheters in both animal and clinical studies. Before undertaking this review, however, a case study will be presented, which will illustrate the subsequent relevant points about the use of the large-tip catheters.
Atrial Flutter Case Study
This case illustrates the rapidity with which atrial flutter ablation may be achieved with the use of a large-tip ablation catheter. The patient is a 52-year-old male who was in a clinical trial conducted by Boston Scientific, Inc. (SanJose, CA, USA), evaluating a large-tip 8-or 10-mm catheter (Blazer XP TM ) and high power 100-W radiofrequency (RF) generator (EPT 1000 XP TM ). 1 Arrhythmia history included recurrent type I atrial flutter with rapid ventricular response. The patient had a normal physical examination and no other medical conditions. A normal physical examination is often an exception in this patient population, in which atrial fibrillation frequently accompanies the flutter. The patients enrolled in this study protocol were limited to those with only atrial flutter. The patient's echocardiogram showed some mild global hypokinesis, an ejection fraction (EF) of 50%, biatrial enlargement, and moderate tricuspid regurgitation. The echo findings suggested a probable tachycardia-induced cardiomyopathy. The atrial flutter was mapped using the Carto TM system (Biosense-Webster, Inc., Diamond Bar, CA, USA), which demonstrated a counterclockwise (CCW) activation pattern in the right atrium (Fig. 1) , and pacing from the tricuspid valve-inferior vena cava isthmus demonstrated concealed entrainment confirming that the flutter was isthmus dependent.
Ablation was performed with a 10-mm tip Blazer XP TM (Boston Scientific, Inc.) ablation catheter. Successful isth-mus ablation was achieved with three RF energy applications between 19 and 103 seconds. During this study power application was discontinued if at anytime it was felt that the catheter had moved off the ablation line, or if tissue contact was lost. Lesions were achieved through a slow continuous drag back. Power was applied in a range from 50 W to 75 W. The maximum temperature target was 60
• C, and the actual temperature achieved ranged between 42
• C and 60
• C. Total fluoroscopy time in this case was only 3.9 minutes. Total procedure time was 45 minutes.
The procedure resulted in bidirectional isthmus block, as demonstrated during pacing from the coronary sinus ostium and low lateral right atrium (Fig. 2) . The clinical trial followed the patients for up to 24 months. There were no further arrhythmia-related symptoms or recurrence of atrial flutter in this patient, as documented by transtelephonic monitoring and 12-lead ECGs. The patient's quality of life improved and ventricular function on echocardiography normalized. This case exemplifies some of the advantages of large-tip RF catheter ablation for atrial flutter. The data that follow further support these observations.
Preclinical Studies of Large-Tip Radiofrequency Ablation Electrode Catheters
The first study examining the effect of electrode length on lesion size using RF energy was performed by Langberg et al. 2 in 1993. This study compared lesions produced by large ablation electrodes ranging from 8-to 12-mm long, to lesions produced by the conventional 4-mm electrodes. The catheters used had thermistors at the tip of the distal electrode. The RF generator used in this study was capable of producing up to 100 W. This study was performed on 10 canines, each receiving multiple left ventricular endocardial lesions. Target temperature was 80
• C with the duration of energy application 60 seconds.
Several important observations were made (Table 1) . First, higher power was required to reach the target temperature of 80
• C with the larger ablation electrodes. Fifteen W was required for the 4-mm catheter, 46 W for the 8 mm, and 62 W for the 12-mm electrodes. Surprisingly, however, the 8-mm electrode catheter produced the largest lesion size. Lesion depth with the 8-mm electrode was 11 mm on average compared to 6 mm with the 4-mm electrode and 8 mm with the 12-mm electrode. Lesion volumes were significantly larger as well using the 8-mm electrode, averaging 905 versus 210 mm 3 for the 4-mm electrode and 465 mm 3 for the 12-mm electrode. There was no charring of tissue produced with either the 4-or 8-mm electrodes, but there was some tissue charring and crater formation with the 12-mm electrode. This suggested that the larger 8-mm ablation electrode had some advantageous properties, but that there appeared to be a point of diminishing return with electrode size >8 mm. At certain limits, larger electrode size was actually associated with a decline in lesion volume and depth and adverse tissue effects. This phenomenon is likely due to the greater energy-dispersive effects of the larger surface area of the longer electrodes, resulting in the significantly higher power required to achieve adequate temperatures for ablation.
Rosenbaum et al. 3 also evaluated the effects of large ablation electrodes and higher RF power on left ventricular endocardial lesions. Steerable electrode catheters with 4-, 8-, and 12-mm tips and power settings of 20, 40, 60, 80, and 100 W were used to create endocardial lesions in 18 canines. Larger electrode size and higher power were found to produce greater lesion volumes. Impedance rises, however, limited the lesion size at higher power with each of the electrodes. The maximal lesion size for the 4-mm tip catheter was about half that seen with the 8-mm tip (460 ± 150 mm 3 vs 914 ± 382 mm 3 , P < 0.01).
Clinical Studies of Large-Tip Radiofrequency Ablation Electrode Catheters
Feld et al. 4 reported in 1995 on work with an 8-mm tip nonthermistor catheter, used with a standard RF generator, which was compared to 4-mm tip catheters in ablation of 34 patients with type I atrial flutter. The results showed a 50% reduction in fluoroscopy and procedure times, and a 50% reduction in the number of ablation lesions required for bidirectional isthmus block. Efficacy in prevention of recurrent atrial flutter was about 50%.
Tsai et al. 5 conducted a prospective, randomized study comparing 4-and 8-mm tip ablation catheters in the treatment of atrial flutter. One hundred and four consecutive patients were studied, 54 treated with the 4-mm tip and 50 with the 8-mm tip. The temperature control was utilized with a preset target of 70
• C. Patient characteristics are seen in Table 2 . Complete isthmus block was achieved with 36 patients (80%) in the 4-mm tip group and 46 (92%) in the 8-mm tip group. Procedure times are summarized in Table 3 . The study concluded that the 8-mm tip was more effective than In 1995, there were no catheters approved by the FDA for atrial flutter ablation. Boston Scientific, Inc., developed a multicenter study protocol to examine the safety and efficacy of 8-and 10-mm electrode ablation catheters and a high-output 100-W RF generator for the treatment of type I, isthmus-dependent atrial flutter.
The catheters included a straight 8-and 10-mm tip electrode and a contoured 8-mm tip electrode. The contoured tip catheter was developed with the hypothesis that its position might be more stable during ablation, particularly at the tricuspid valve annulus (Fig. 3) .
The study criteria included clinical evidence of atrial flutter with an atrial rate between 240 and 350 beats/min, unless the patients were on a IC antiarrhythmic drug or amiodarone, in which case the rate could be slower. Patients were not required to have failed antiarrhythmic therapy. At least one or more episodes of atrial flutter had to have been documented by ECG rhythm strip, and the patient had to have reported at least two episodes of arrhythmia symptoms in the previous 12 months. At EP study, confirmation of a type I isthmusdependent atrial flutter was required. Patients had to range in age between 18 and 80 years.
One hundred and sixty-nine patients were enrolled. Table 4 summarizes this group. The mean age of participants was 61 years. Over half of the participants had left atrial enlargement. About a quarter to a third of patients had evidence of other chamber enlargement. Sixty-six percent had an EF over 50%, but 24% of patients had an EF < 50%. In about 10% of patients echocardiograms did not report an EF, thus those data are not available. Antiarrhythmic drugs were being taken by 23% of the patients. There was a history of atrial fibrillation in 19% of the patients. Patients with a history of atrial fibrillation could be included in the study if they were not being actively treated for atrial fibrillation. Electrophysiologic testing confirmed the diagnosis of isthmus-dependent CCW flutter in 129 patients, clockwise flutter in 31, and both forms in 4 patients. The flow diagram in Figure 4 summarizes the results. Initially, 1076 patients were screened, with a total of 169 patients meeting study criteria and being enrolled. Acute treatment success was defined as the achievement of bidirectional isthmus block and no inducible atrial flutter following ablation. Acute treatment success was achieved in 158 patients. These patients were seen in follow-up at 1, 3, and 6 months in clinic and had event monitoring done weekly and with any symptomatic event. At 6 months, 112 patients had no recurrence of atrial flutter. Four patients had a flutter recurrence and 42 patients were considered not evaluable for various reasons. Twenty patients were treated with antiarrhythmic drugs for a subsequent occurrence of atrial fibrillation or other atrial arrhythmias. There were four deaths not related to the procedure itself, 11 patients ultimately went on to have pacemakers implanted, and two were lost to follow-up. One patient developed persistent atrial fibrillation and four withdrew from the study voluntarily. Thus, of the 116 who could be followed up 112 had no recurrence, for an overall long-term cure rate of 96%. Acutely there were 11 failures, defined as the inability to produce isthmus block with an investigational catheter. Of these, two were successfully ablated with an approved conventional catheter, while seven were not successfully ablated. In the two remaining cases, investigational catheters were not used due to RF generator malfunctions, and these patients were successfully ablated with approved systems.
Total procedure time was 2 hours on average, with an average time to complete ablation of 39 minutes. Fluoroscopy time averaged 28 minutes. A mean of 12 ablations, with a median of 7 were required to produce isthmus block. The average duration of each RF energy application was 73 seconds, with the average power setting at 78 W and average power delivered being 55 W. Average temperature targeted was 64
• C with a mean of 55 • C achieved (Table 5) .
In this study, of the 150 patients in whom a single investigational catheter was used, 49% were ablated with the 10-mm tip catheter, 35% with the 8-mm straight tip catheter, and 17% with the contoured 8-mm tip catheter. This study was not randomized with respect to catheter type, though there was a good distribution of each to compare efficacy (Table 6 ). Although the acute efficacy was not different at 95% versus 98% between the 10-and 8-mm tip catheters, the actual number of ablations required (i.e., 10 vs 14) was less for the 10-mm tip catheter. The mean time required for ablation to achieve acute success was also less, 0.5 versus 0.8 hours, with the 10-versus 8-mm tip catheters. Thus, there appears to be at least some statistically significant technical advantage of the 10 mm over the 8-mm tip catheter in this study.
A fairly extensive quality-of-life assessment was conducted with three different types of questionnaires. Eight of the 13 parameters showed a statistically significant improvement at follow-up (Table 7) , indicating that these patients felt much better overall having had their flutter cured.
There were eight major adverse events in six patients, a total of 3.6% out of the 169 treated, but no deaths. This is actually comparable to or better than most studies in the reported literature for atrial flutter ablation. These complications included pulmonary embolism; a fractured femur that was not related to the study but possibly some nursing or hospital care issues; lower extremity ischemia that was due to systemic embolism; deep venous thrombosis; groin hematoma; a cerebral infarct that was not felt to be related to the procedure and one that was. These patients were on anticoagulants during the procedure, but anticoagulation with warfarin prior to ablation was not required by the protocol. Thus, as is well known now, there is a potential even with atrial flutter ablation for systemic embolism including cerebral infarct. Consequently, more recently, electrophysiologists are probably more cautious about this problem in patients with atrial flutter than in the past. There were no coronary lesions noted during this study, and no valvular damage. A minimal amount of coagulum was reported developing on catheters during the study. There was no correlation between the use of high power or large electrodes and adverse effects, but a history of thromboembolism was associated with the occurrence of major adverse events.
Conclusions
Ablation of type I isthmus-dependent atrial flutter with 8-or 10-mm tip electrodes, compared with standard 4-of 5-mm tip electrodes, is associated with shorter procedure times, equal or greater efficacy, and no significant increase in complication rate. Successful ablation of atrial flutter with large-tip electrodes is also associated with an improved quality of life. Thus, this study suggests that large-tip electrode catheters coupled with a high-power RF generator are highly efficacious and safe for ablation of isthmus-dependent type I atrial flutter.
